Over $2M Bet On Akero Therapeutics? Check Out These 3 Stocks Insiders Are Buying
Portfolio Pulse from Lisa Levin
Insider trades were noted in Akero Therapeutics, Crocs, and The Bancorp. Akero Therapeutics Director Walmsley Graham acquired 55,000 shares at an average price of $42.95, costing around $2.36 million. Crocs Director Thomas Smach acquired 1,435 shares at an average price of $104.53, costing around $150,001. The Bancorp Director Matthew Cohn bought 5,868 shares at an average price of $37.61, costing around $220,688.
August 04, 2023 | 10:58 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Akero Therapeutics Director acquired 55,000 shares, indicating confidence in the company.
Insider buying often indicates confidence in the company's prospects. This could potentially lead to a positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Crocs Director acquired 1,435 shares, indicating confidence in the company.
Insider buying often indicates confidence in the company's prospects. This could potentially lead to a positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
The Bancorp Director bought 5,868 shares, indicating confidence in the company.
Insider buying often indicates confidence in the company's prospects. This could potentially lead to a positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100